Cargando…
重组人血小板生成素对非重型再生障碍性贫血免疫抑制治疗疗效的影响
OBJECTIVE: To compare the efficacy of cyclosporin A (CsA) alone and CsA combined with recombined human thrombopoietin (rhTPO) in patients with non-severe aplastic anemia (NSAA). METHODS: Data from 83 patients with NSAA between August 2014 and February 2019 were collected retrospectively. The study p...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525171/ https://www.ncbi.nlm.nih.gov/pubmed/32942816 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.08.004 |
Ejemplares similares
-
重组人血小板生成素对重型再生障碍性贫血免疫抑制治疗近期疗效的影响
Publicado: (2015) -
重组人血小板生成素对重型再生障碍性贫血患者异基因造血干细胞移植后血小板恢复的影响
Publicado: (2018) -
艾曲泊帕、重组人血小板生成素联合标准免疫抑制治疗重型再生障碍性贫血16例疗效及安全性分析
Publicado: (2021) -
比较不同重组人TPO方案联合免疫抑制治疗对重型再生障碍性贫血近期疗效的影响
Publicado: (2016) -
血小板生成素受体激动剂改善重型再生障碍性贫血疗效的研究进展
Publicado: (2017)